Delivery Order SPE2DB20D6037-SPE2DB24FTWT5

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,365.40 award is for the supply of the prescription drug Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The delivery order has a completion date of May 9, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $26,315.15 contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml injections, with a period of performance through May 15, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $3,870.48 contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,870.48 firm fixed-price delivery order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,740.96 contract is for the delivery of the prescription drug Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, with a period of performance through September 25, 2023. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA that provides a comprehensive range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,019.24, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has an ultimate completion date of March 25, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, with a ceiling value of $16,090.28. The award is for the delivery of 4 mg/3 mL Ozempic injections. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,740.96 contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 mL) 3mL medication. This delivery order is part of a larger $499,999,999 single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC enables the DLA...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials. The total potential value of this delivery order is $11,611.44 with a period of performance through January 16, 2024. DMS Pharmaceutical Group is an experienced federal contractor that holds multiple contracts and indefinite delivery vehicles with DLA to supply a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,939.52 order is for the supply of Ozempic (semaglutide) 1 mg/dose medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue firm...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB24FTWT5
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,749.94 order is for the drug Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, with a completion date of August 23, 2024.

DMS Pharmaceutical Group holds a $499,999,999 single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military healthcare facilities worldwide. This delivery order is issued under that larger IDC vehicle, solidifying DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 11/21/24, 9:13 AM